(Rac)-Tanomastat is an orally bioavailable, zinc-binding, non-peptidic biphenyl matrix metalloproteinase (MMP) inhibitor with anti-invasive and anti-metastatic activity in several experimental tumor models; it inhibits MMP-2, MMP-3, MMP-9, and MMP-13 with Ki values of 11, 143, 301, and 1470 nM, respectively.